Maintaining business continuity during COVID-19
Lessons learned will have positive impacts beyond the pandemic
Overcoming autologous cell therapy logistics challenges in the age of COVID-19
Experienced team for managed logistics is key
How COVID-19 is changing the production of cell therapies
Implementation of contingency plans allows for continued progress in therapy development
Managing donor collections during the COVID-19 pandemic
Why a diverse apheresis center network is critical to business continuity
Quality Starting Material: The Driving Force Behind Life-Saving Cell Therapies
By Jamie Margolis, PhD, Senior Vice President of Donor Services, NMDP/Be The Match
Overcoming challenges to cellular starting material collection
Q&A with the Be The Match BioTherapies Collection Network Liaison team
The challenge of multiple audits and redundant training
A case study from UCLA Health
Developing and managing a strong collection center network
On-demand webinar available
